Drug intelligence / Profile preview

N-[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-N',N'-dimethyl-benzene-1,4-diamine

Development stage
Unknown
Modality
Small Molecules
01

Overview

This compound is a synthetic small molecule with the chemical formula C17H19N5S and a molecular weight of approximately 325.43 g/mol[3][5]. It belongs to the class of organic compounds known as 2,4,5-trisubstituted thiazoles[3]. The molecule has been studied as an experimental agent and is not approved for clinical use in any country[3]. Its primary mechanism of action is inhibition of cyclin-dependent kinase 2 (CDK2), an enzyme involved in cell cycle regulation. In biochemical assays it demonstrates inhibitory activity against CDK2 with IC50 values in the low nanomolar range (IC50 ≈ 220 nM; Ki ≈ 251 nM)[3][4]. There are no reported clinical indications or marketed formulations for this compound.

Other names
N-[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-N',N'-dimethyl-benzene-1,4-diamineN-(4-(2,4-dimethyl-thiazol-5-YL)-pyrimidin-2-YL)-N',N'-dimethyl-benzene-1,4-diamineN4-(4-(dimethyl-1,3-thiazol-5-yl)pyrimidin–2–yl)–N1,N1–dimethylbenzene–1,4–diamine
02

Targets

CDK9 (Cyclin-dependent kinase 9)CDK2 (Cyclin-dependent kinase 2)

Beyond the preview

Go deeper on N-[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-N',N'-dimethyl-benzene-1,4-diamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-N',N'-dimethyl-benzene-1,4-diamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call